HSG Treatment Approach
Distal Lateral Subungual Onychomycosis (DLSO) is the most common type of toenail onychomycosis. The nail bed is the primary site of fungal invasion, although the matrix and nail plate are implicated as well. Pathogenic fungi (“dermatophytes”) invade the nail bed under detached nail at the distal edge, an anatomical opening created by trauma induced onycholysis. Over time, the underlying fungal colonies advance in a proximal direction towards the lunula reflecting signs of nail destruction along the way. Visible symptoms of disease progression include expanding yellow-white-brown sections of nail, jagged fine lines and borders, subungual hyperkeratosis, and in some more severe conditions, distinct fungal masses called dermatophytoma. If left untreated, these clinical signs will worsen over the years, eventually occupying the entire nail plate.
To resolve DLSO, the administered antifungal must kill all active pathogens across the nail bed thus allowing newly formed nail produced in the matrix to grow out disease-free. Oral medications attempt to accomplish this through systemic delivery but are associated with side effects such as drug interactions and the potential for liver damage. Most patients seek to avoid these events by opting for non-systemic topicals, especially seniors. But these lacquers & solutions self applied onto the outer nail by brush applicator or dropper, only work on mild infection and only after a year of continuous daily application. Patients with moderate to severely infected toes have the toughest challenge as their nails are dystrophic and can worsen by age and co-morbidities. The presence of dermatophytoma fungal mass presents a special challenge as it can be encapsulated by a protective biofilm that renders it refractory to monotherapy unless adjunct mechanical intervention is undertaken.
Once FDA approved, HSG would represent a new treatment option for mild-to-severe fungal nails. A physician applies the special gel formulation by a cannula-based subungual applicator directly onto the mycotic nail bed providing high fungicidal activity at the infection site and eventual resolution of the disease. The provider can often treat the affected nail area they plainly see. The topical procedure takes less than one minute for a great toe and less than 7 minutes for all affected toes. Podiatrists, who treat the majority of fungal nails, are expected to be high adopters of HSG and will use HSG as an antifungal solution when providing care for their patients.

